Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01324596 |
|---|---|
| Brief Title: | A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib (REMoDL-B) |
| First Submitted : | March 25, 2011 |
| First Submitted that Met QC Criteria : | March 28, 2011 |
| First Posted : | March 29, 2011 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 14, 2016 |
| Last Update Posted : | April 15, 2016 (Estimate) |